These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7903516)

  • 1. H1-receptor antagonists: does a dose-response relationship exist?
    Simons FE
    Ann Allergy; 1993 Dec; 71(6):592-7. PubMed ID: 7903516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H1-antihistamines in children.
    Simons FE
    Clin Allergy Immunol; 2002; 17():437-64. PubMed ID: 12113226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiallergic anti-inflammatory effects of H1-antihistamines in humans.
    Assanasen P; Naclerio RM
    Clin Allergy Immunol; 2002; 17():101-39. PubMed ID: 12113215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H1-antihistamines in the elderly.
    Kaliner MA
    Clin Allergy Immunol; 2002; 17():465-81. PubMed ID: 12113227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation H1-receptor antagonists.
    Simons FE; Simons KJ
    Ann Allergy; 1991 Jan; 66(1):5-16, 19. PubMed ID: 1670985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
    Wang RQ; Zhang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H1-antihistamines and the central nervous system.
    Welch MJ; Meltzer EO; Simons FE
    Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
    Deschamps C; Dubruc C; Mentre F; Rosenzweig P
    Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the pharmacotherapy of allergic rhinitis: second-generation H1-receptor antagonists.
    Corey JP
    Otolaryngol Head Neck Surg; 1993 Sep; 109(3 Pt 2):584-92. PubMed ID: 8105440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines.
    Hansen J; Klimek L; Hörmann K
    Drugs Aging; 2005; 22(4):289-96. PubMed ID: 15839718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The advisability of using antihistamine preparations and their therapeutic efficacy].
    Borodin IuP; Il'ina OV
    Voen Med Zh; 1989 Sep; (9):27-30. PubMed ID: 2574519
    [No Abstract]   [Full Text] [Related]  

  • 13. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroencephalogram and behavioral changes induced by histamine application into the nasal cavity and the effects of some H(1)-receptor antagonists.
    Ashequr RM; Kamei C
    Int Immunopharmacol; 2005 Nov; 5(12):1741-8. PubMed ID: 16102524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation.
    Simons FE
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of fexofenadine--selective antagonist of histamine receptor (H1) on histamine-induced bronchoconstriction].
    Grzelewska-Rzymowska I; Kroczyńska-Bednarek J; Pietrzkowicz M
    Pol Merkur Lekarski; 2003 Jan; 14(79):43-6. PubMed ID: 12712828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihistamines in rhinoconjunctivitis.
    Howarth P
    Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitis.
    Trattler WB; Luchs J; Majmudar P
    Int Ophthalmol Clin; 2006; 46(4):87-99. PubMed ID: 17060795
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacology and use of H1-receptor-antagonist drugs.
    Simons FE; Simons KJ
    N Engl J Med; 1994 Jun; 330(23):1663-70. PubMed ID: 7909915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.